A number of spin-out companies have been formed by research scientists from the School of Medicine. Click on the logos below to find out more about each of them.
is a biopharmaceutical company focussed on the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need.
FaHRAS combines expert advice from leading clinicians with cutting-edge technology.
Gamma Technologies focuses on the development of high resolution imaging systems for use in nuclear medicine.
NGD (Nottingham Gynaecological Devices) Limited is a University of Nottingham spin out company incorporated in July 2006.
was incorporated on 10 July 2014. The company aims to develop, validate and commercialise innovative and cost effective ophthalmic regenerative therapies to save sight.
Oncimmune was set up in 2003 to commercialise a test to detect cancer.
Platelet Solutions was formed in 2011 focussing on platelet function testing in any healthcare setting.
Scancell’s mission is to overcome this breach in our defences by developing products that stimulate the immune system to treat or prevent cancer.